Page last updated: 2024-11-02

pilsicainide and Atrial Ectopic Beats

pilsicainide has been researched along with Atrial Ectopic Beats in 1 studies

pilsicainide: structure given in first source
pilsicainide : A secondary carboxamide resulting from the formal condensation of the amino group of 2,6-dimethylaniline with the carboxy group of (tetrahydro-1H-pyrrolizin-7a(5H)-yl)acetic acid. It is a sodium channel blocker which is used as an antiarrhythmic drug for the management of atrial tachyarrhythmias in Japan.

Research Excerpts

ExcerptRelevanceReference
"Appropriate dosing of pilsicainide hydrochloride, an anti-arrhythmic drug excreted via the kidney, was investigated in patients on dialysis."1.31Appropriate dosing of pilsicainide hydrochloride in patients on hemodialysis. ( Fujii, Z; Fujimoto, K; Kawata, Y; Matsumoto, M; Matsuzaki, M; Minami, M; Nawata, C; Sakumura, T, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Matsumoto, M1
Fujii, Z1
Kawata, Y1
Sakumura, T1
Minami, M1
Fujimoto, K1
Nawata, C1
Matsuzaki, M1

Other Studies

1 other study available for pilsicainide and Atrial Ectopic Beats

ArticleYear
Appropriate dosing of pilsicainide hydrochloride in patients on hemodialysis.
    Nephron, 2001, Volume: 88, Issue:2

    Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Premature Complexes; Echocardiography; Electroc

2001